BlackRock, Inc. 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Cytosorbents Corporation CTSO |
BlackRock Inc. BLK |
744,958 1.700% |
-1,886,252 (-71.69%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Cytosorbents Corporation CTSO |
BlackRock Inc. BLK |
2,631,210 6.100% |
-131,078 (-4.75%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Cytosorbents Corporation CTSO |
BlackRock Inc. BLK |
2,762,288 6.400% |
702,686 (+34.12%) |
Filing |